Iyer, P. C., Dadu, R., Gule-Monroe, M., Busaidy, N. L., Ferrarotto, R., Habra, M. A., . . . Cabanillas, M. E. (2018). Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma. J Immunother Cancer.
Styl cytowania ChicagoIyer, Priyanka C., et al. "Salvage Pembrolizumab Added to Kinase Inhibitor Therapy for the Treatment of Anaplastic Thyroid Carcinoma." J Immunother Cancer 2018.
Styl cytowania MLAIyer, Priyanka C., et al. "Salvage Pembrolizumab Added to Kinase Inhibitor Therapy for the Treatment of Anaplastic Thyroid Carcinoma." J Immunother Cancer 2018.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..